199444-17-2Relevant academic research and scientific papers
Low molecular weight dendritic compounds as pharmaceutical agents
-
, (2008/06/13)
This invention is for low molecular weight dendritic polymers (dendroids) of Formula I are useful as agents in the treatment of cancer, Alzheimers disease, thrombosis, inflammatory diseases, and bacterial resistance.
Dendroids: A building block for the synthesis of polymodal dendritic structures
Allen, Joanne V.,Horwell, David C.,Lainton, Julia A. H.,O'Neill, Jacqueline A.,Ratcliffe, Giles S.
, p. 2121 - 2122 (2007/10/03)
Differentially substituted 1,8-naphthalene and 1,2,3-trihydroxybenzene derivatives are synthesised and termed 'dendroids'; these may be differentially derivatised with mimetics of amino acid side chains.
